Karen Bradshaw
Nurse Practitioner · Midlothian, VANPI 1982986816
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,135 and has fallen 98.5% since, to $18 in 2025. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$265
- AbbVie$188
- Lilly USA, LLC$176
- Novo Nordisk$162
- Johnson & Johnson$140
- Abbott$139
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,417100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 18 | $265 |
| AbbVie | 11 | $188 |
| Lilly USA, LLC | 12 | $176 |
| Novo Nordisk | 11 | $162 |
| Johnson & Johnson(2 entities) | 6 | $140 |
| Abbott | 6 | $139 |
| Merck | 7 | $116 |
| Boehringer Ingelheim | 6 | $99 |
| Insightec,inc | 2 | $96 |
| Bayer | 7 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $88 |
| Biogen | 4 | $71 |
| Jazz Pharmaceuticals Inc. | 3 | $63 |
| AstraZeneca | 4 | $57 |
| Dexcom, Inc. | 3 | $57 |
| Sanofi-aventis U.S. LLC | 4 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Dynavax Technologies Corporation | 3 | $47 |
| Pfizer | 3 | $43 |
| Bausch Health US, LLC | 2 | $42 |
| Novartis | 3 | $38 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| GSK | 2 | $27 |
| Amarin Pharma, Inc. | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Edwards Lifesciences | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Philips North America LLC | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Corium, LLC | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
| Clarus Therapeutics Inc. | 1 | $10 |
How this compares
$2,417 in reported general payments places this provider in the 90th percentile of 2,166 nurse practitioner providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 49 | $384 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Midlothian
- Julie JulianMidlothian$14K
- Kelly McAuliffeMidlothian$9K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
- Rachel AndersonCharlottesville$90K
- Megan FrancisArlington$81K
- Elizabeth WilletteNorfolk$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.